Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-30

FDA Approved: RASAGILINE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved Ascend Laboratories' original application for rasagiline as a generic treatment for Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RASAGILINE (rasagiline)

Snippet

ORIG AP for RASAGILINE (RASAGILINE)